BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Deals

Tacere, Oncolys BioPharma deal

Tacere reacquired development and commercialization rights in Asia to its family of HCV compounds, including TT-033 and TT-034, after it and Oncolys mutually terminated a 2007...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >